DGI-033 Evaluation of Crizotinib Treatment in Patients with Non-Small Cell Lung Cancer
AM Villalba-Moreno, T Trinidad-Desongles… - European Journal of …, 2013 - ejhp.bmj.com
Background Crizotinib is a cytostatic oral ALK inhibitor, a newly-introduced oral cytostatic to
treat non-small cell lung cancer (NSCLC) that has been accessible through an expanded …
treat non-small cell lung cancer (NSCLC) that has been accessible through an expanded …